State Street’s Envoy Medical COCH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$16.3K Hold
2,387
– – ﹤0.01% 4272
2026
Q2
$18.9K Hold
2,387
– – ﹤0.01% 4219
2026
Q1
$15.9K Hold
2,387
– – ﹤0.01% 4231
2025
Q4
$15.8K Hold
2,387
– – ﹤0.01% 4256
2025
Q3
$18.5K Hold
2,387
– – ﹤0.01% 4252
2025
Q2
$33.9K Hold
2,387
– – ﹤0.01% 4149
2025
Q1
$31K Hold
2,387
– – ﹤0.01% 4154
2024
Q4
$35.1K Hold
2,387
– – ﹤0.01% 4165
2024
Q3
$77.6K Hold
2,387
– – ﹤0.01% 4025
2024
Q2
$56.3K Sell
2,387
-1,120
-32% -$41.7K ﹤0.01% 4119
2024
Q1
$137K Buy
+3,507
New +$103K ﹤0.01% 3963

Other funds holding COCH

State Street's COCH Position: Q3 2026 in Review

State Street held its Envoy Medical (COCH) position steady in Q3 2026 at 2,387 shares worth $16.3K. The position accounts for ﹤0.01% of the portfolio, ranked #4272.

State Street first reported a position in COCH in Q1 2024 and has held it in 11 quarters since. The position peaked at $137K in Q1 2024. 14 funds tracked by Wall St. Rank hold COCH as of Q3 2026.

  • State Street held 2,387 shares of Envoy Medical worth $16.3K as of Q3 2026.
  • State Street left its Envoy Medical share count unchanged in Q3 2026.
  • Envoy Medical made up ﹤0.01% of State Street's portfolio in Q3 2026, its #4272 holding.
  • State Street first reported a position in Envoy Medical in Q1 2024 and has held it in 11 quarters since.
  • State Street's Envoy Medical position peaked at $137K in Q1 2024.
  • 14 funds tracked by Wall St. Rank held Envoy Medical as of Q3 2026.

Based on State Street's 13F filing for Q3 2026, filed 12 Nov 2026.